Uprising — Full Portfolio
6 tracked investments · listed companies and verified rows first
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+19 more
Good Eggs is an online grocery service that delivers fresh produce, groceries, and food products to consumers.
Direct to ConsumerE-commerceFoodTechMarketplacesOakland, US
Alon Salant(Founder)inRob Spiro(Founder)inGeorgina Bale(Co-founder)Bentley Hall(Former Chief Executive Officer)inKeith Brewer(Chief Executive Officer)Rodrigo Arevalo(Former Chief Executive Officer)in
Co-investorsBaseline VenturesCollaborative FundCorrelation VenturesDns CapitalDYDX CapitalFinistere Ventures+15 more
HR TechVancouver, CA
Co-investorsTechstarsBain CapitalBain Capital VenturesFirework VenturesHLM Investment PartnersHopelab+1 more
Hazel Health operates a school-based telehealth platform that connects students with licensed clinicians for healthcare services.
Digital HealthEdTechHealthtech
Co-investorsBain Capital VenturesHLM Investment PartnersOwl VenturesFirework VenturesHopelab
Hazel makes disposable, leakproof briefs designed to look and feel like regular underwear for people experiencing urinary incontinence, including women postpartum.
ConsumerDirect to ConsumerFemTechWellness & Fitness
Co-investorsBAM VenturesBroad Street AngelsEntrepreneurs Roundtable Accelerator (ERA)H Venture PartnersOvereasy VenturesBain Capital+6 more
Psychedelic therapies for addiction.
BiotechSan Francisco, US
Jeeshan Chowdhury(Executive Officer, Director, Promoter)in
BoardSam Altman(Director)inKrishna Kantheti(Director)
Co-investorsMBX CapitalAPOLLO PROJECTSLIONHEART VENTURES
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




























